Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports

Overview of attention for article published in BMC Medicine, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 10 X posts from 8 X users, with an upper bound of 16,573 followers.

リスペリドンとパリペリドンの利点と害な～っがい長い (；^ω^) https://t.co/aYW3YOoifX

RT @drAlexHodkinson: See our new methods review assessing the benefits and harms of the antipsychotics Risperidone and Paliperidone involvi…

RT @Dr_MPanagioti: Our star methodologist @drAlexHodkinson has led a novel-method meta-analysis combining IPD+Clinical Study Reports to ass…

RT @Dr_MPanagioti: Our star methodologist @drAlexHodkinson has led a novel-method meta-analysis combining IPD+Clinical Study Reports to ass…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.